# Improving How Blood Platelets Are Stored > This patent describes new chemical compounds and methods to prevent damage to blood platelets when they are stored, like in blood banks, making them last longer and more effective for transfusions. - **Patent:** US 12733635 - **Original title:** Platelet storage methods and compositions - **Granted:** 2026 - **Status:** Active - **Times cited:** 0 - **Field:** biotech, pharmaceutical, medical_devices, healthcare ## What it does The patent introduces specific chemical compounds, referred to as 'formula I,' and compositions containing them. These compounds are designed to slow, prevent, or even reverse damage to platelets. This damage often happens during blood banking or when platelets are kept cold. By using these compounds, the patent aims to improve how long platelets survive after being transfused into a patient. For example, a blood bank could add these special compounds to bags of platelets before refrigeration to ensure they remain viable for a longer period. ## What it does NOT cover - Does not cover methods for storing whole blood or other blood components like red blood cells or plasma. - Does not cover methods of platelet storage that do not involve the specific chemical compounds described by 'formula I'. - Does not cover diagnostic methods for assessing platelet damage or viability. - Does not cover treatments for platelet disorders that are not related to storage damage. ## The clever bit The novelty lies in identifying specific chemical structures (compounds according to 'formula I') that can effectively protect platelets from common storage-related damage, particularly cold-induced injury, without negatively affecting their crucial function upon transfusion. This precise chemical intervention aims to overcome a long-standing challenge in blood banking. ## Real-world examples 1. Blood banks 2. Hospitals performing transfusions 3. Trauma centers 4. Cancer treatment facilities 5. Military field hospitals ## Why it matters Platelets are essential for blood clotting and are frequently needed by patients with cancer, severe injuries, or those undergoing major surgery. However, platelets have a very short shelf life, typically only 5-7 days, even with current storage techniques. This short window often leads to waste and can make it challenging to maintain a sufficient supply. This patent aims to extend that shelf life, which could significantly reduce waste and ensure more platelets are available when critically needed. ## Frequently asked questions ### What does Improving How Blood Platelets Are Stored cover? This patent describes new chemical compounds and methods to prevent damage to blood platelets when they are stored, like in blood banks, making them last longer and more effective for transfusions. ### When does this patent expire? This patent is expected to expire on September 15, 2046, when the invention enters the public domain. ### What problem does this patent solve? Platelets are essential for blood clotting and are frequently needed by patients with cancer, severe injuries, or those undergoing major surgery. However, platelets have a very short shelf life, typically only 5-7 days, even with current storage techniques. This short window often leads to waste and can make it challenging to maintain a sufficient supply. This patent aims to extend that shelf life, which could significantly reduce waste and ensure more platelets are available when critically needed. ### What does this patent NOT cover? Does not cover methods for storing whole blood or other blood components like red blood cells or plasma. **Full plain-English explainer:** https://patentbrief.org/patent/us/12733635/platelet-storage-methods-and-compositions **Original patent:** https://patents.google.com/patent/US12733635 --- _Source: PatentBrief — https://patentbrief.org. Patent facts are from public records; the plain-English explanation is PatentBrief's._ ## Related patents Semantically similar inventions in the PatentBrief corpus: - [Using Antibodies to Protect Transplanted Organs from Damage](https://patentbrief.org/patent/us/10400035/ocrevus-ocrelizumab) — A medical method for preserving transplanted organs by using specific antibodies to block a protein that causes inflammation and blood vessel leakage. - [Chemical Compounds for Treating Hepatitis C Virus](https://patentbrief.org/patent/us/8822430/epclusa-sofosbuvir-velpatasvir) — A patent describing specific chemical structures designed to stop the Hepatitis C virus from replicating in humans. - [How to Make Anthrax Vaccines That Survive Freezing](https://patentbrief.org/patent/us/10357559/luxturna-voretigene-neparvovec) — A method for protecting sensitive anthrax vaccines from damage during freezing and thawing by using specific sugars and additives during the drying process. - [Improving Drug Delivery with Chemical Masks for Thiazolo-Pyrimidine Compounds](https://patentbrief.org/patent/us/7528115/eylea-aflibercept) — A patent describing modified chemical structures that act as dormant precursors, designed to be activated by the body to help treat viral infections like Hepatitis C. - [How Synthetic Peptides Block Immune System Overreaction](https://patentbrief.org/patent/us/10106579/orkambi-lumacaftor-ivacaftor) — A patent describing specific synthetic peptides designed to stop the body's immune system from attacking healthy cells by blocking a protein called C5.